LeMaitre Vascular, Inc. $LMAT Shares Purchased by Public Sector Pension Investment Board

Public Sector Pension Investment Board raised its holdings in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 15.8% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 81,211 shares of the medical instruments supplier’s stock after acquiring an additional 11,092 shares during the quarter. Public Sector Pension Investment Board owned approximately 0.36% of LeMaitre Vascular worth $7,107,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Parkside Financial Bank & Trust increased its stake in shares of LeMaitre Vascular by 1,913.3% during the 2nd quarter. Parkside Financial Bank & Trust now owns 302 shares of the medical instruments supplier’s stock worth $25,000 after purchasing an additional 287 shares in the last quarter. Cornerstone Planning Group LLC lifted its stake in LeMaitre Vascular by 534.0% in the 3rd quarter. Cornerstone Planning Group LLC now owns 336 shares of the medical instruments supplier’s stock valued at $30,000 after buying an additional 283 shares in the last quarter. First Horizon Corp acquired a new stake in LeMaitre Vascular during the 3rd quarter valued at $39,000. Geneos Wealth Management Inc. increased its position in LeMaitre Vascular by 250.3% during the first quarter. Geneos Wealth Management Inc. now owns 557 shares of the medical instruments supplier’s stock worth $47,000 after buying an additional 398 shares in the last quarter. Finally, EverSource Wealth Advisors LLC purchased a new position in LeMaitre Vascular during the second quarter worth $47,000. Hedge funds and other institutional investors own 84.64% of the company’s stock.

LeMaitre Vascular Stock Performance

NASDAQ LMAT opened at $89.25 on Wednesday. The company has a debt-to-equity ratio of 0.44, a current ratio of 13.58 and a quick ratio of 11.45. LeMaitre Vascular, Inc. has a 1-year low of $71.42 and a 1-year high of $105.55. The firm has a market capitalization of $2.03 billion, a P/E ratio of 38.47, a P/E/G ratio of 1.94 and a beta of 0.72. The business’s 50-day simple moving average is $85.05 and its 200-day simple moving average is $88.04.

Wall Street Analyst Weigh In

A number of research firms recently commented on LMAT. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of LeMaitre Vascular in a research note on Monday, December 29th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $95.00 price target on shares of LeMaitre Vascular in a research note on Monday, November 10th. Wells Fargo & Company cut their price objective on shares of LeMaitre Vascular from $97.00 to $93.00 and set an “equal weight” rating for the company in a research report on Friday, November 7th. Wall Street Zen lowered shares of LeMaitre Vascular from a “buy” rating to a “hold” rating in a research report on Saturday, December 6th. Finally, Zacks Research cut shares of LeMaitre Vascular from a “strong-buy” rating to a “hold” rating in a research note on Thursday, January 1st. Four analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $100.20.

LeMaitre Vascular Company Profile

LeMaitre Vascular, Inc is a specialty medical device company focused on the development, manufacture and marketing of products for the treatment of peripheral vascular disease. Headquartered in Burlington, Massachusetts, the company’s offerings include a broad portfolio of vascular surgical instruments, grafts, patches, catheters and embolic protection devices. LeMaitre’s product lines address key areas such as arterial reconstruction, endovascular repair and vascular access, serving the needs of cardiovascular surgeons and interventional specialists.

Founded in 1983 by George D.